CL2021003410A1 - Sistema para proporcionar control de la natalidad - Google Patents

Sistema para proporcionar control de la natalidad

Info

Publication number
CL2021003410A1
CL2021003410A1 CL2021003410A CL2021003410A CL2021003410A1 CL 2021003410 A1 CL2021003410 A1 CL 2021003410A1 CL 2021003410 A CL2021003410 A CL 2021003410A CL 2021003410 A CL2021003410 A CL 2021003410A CL 2021003410 A1 CL2021003410 A1 CL 2021003410A1
Authority
CL
Chile
Prior art keywords
birth control
providing
providing birth
preventative
thirteen
Prior art date
Application number
CL2021003410A
Other languages
English (en)
Inventor
Bruce Variano
Original Assignee
The Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Population Council Inc filed Critical The Population Council Inc
Publication of CL2021003410A1 publication Critical patent/CL2021003410A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente descripción se relaciona con un sistema vaginal que previene el embarazo comprendido por acetato de segesterona y etinilestradiol y está configurado para trece ciclos de uso de producto de 28 días.
CL2021003410A 2019-06-21 2021-12-20 Sistema para proporcionar control de la natalidad CL2021003410A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/448,399 US10918649B2 (en) 2019-06-21 2019-06-21 System for providing birth control

Publications (1)

Publication Number Publication Date
CL2021003410A1 true CL2021003410A1 (es) 2022-10-07

Family

ID=71528001

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021003410A CL2021003410A1 (es) 2019-06-21 2021-12-20 Sistema para proporcionar control de la natalidad

Country Status (15)

Country Link
US (5) US10918649B2 (es)
EP (1) EP3986375A1 (es)
JP (1) JP2022536836A (es)
KR (1) KR20220027979A (es)
CN (1) CN114364369A (es)
AR (1) AR120976A1 (es)
AU (1) AU2020294780A1 (es)
BR (1) BR112021025853A2 (es)
CA (1) CA3141077A1 (es)
CL (1) CL2021003410A1 (es)
CO (1) CO2021017509A2 (es)
IL (1) IL289135A (es)
MX (1) MX2022000047A (es)
WO (1) WO2020257544A1 (es)
ZA (1) ZA202110288B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
US11529308B2 (en) * 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2616064A1 (de) 1976-04-09 1977-10-20 Schering Ag Vaginalring iii
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
TW358031B (en) 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
HUP0004967A2 (en) 2000-12-18 2002-09-28 Richter Gedeon Vegyeszet New crystalline form of nestorone and process for the preparation thereof
EP2170276B1 (en) 2007-06-26 2018-08-22 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
DK2359807T3 (en) 2008-02-04 2017-10-16 Ferring Bv Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof
DE102010003494A1 (de) 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US8580294B2 (en) * 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CN103619914B (zh) * 2011-05-30 2016-09-07 道康宁东丽株式会社 有机聚硅氧烷弹性体及其运用
JP2013011233A (ja) 2011-06-29 2013-01-17 Mitsubishi Heavy Ind Ltd 風力発電装置保守装置および風力発電装置保守方法
CN107955052A (zh) 2011-12-23 2018-04-24 晶体制药独资有限公司 炔基化16-取代-17-酮基类固醇的方法
CN104271084B (zh) * 2011-12-29 2017-03-01 智利大学 包含dhea或硫酸dhea和任选地包含调节该活性成分的释放的试剂的阴道环
EP2800775B1 (en) * 2012-01-04 2018-04-18 Momentive Performance Materials Inc. Curable compositions of ionic silicones
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3209251A4 (en) 2014-10-22 2018-03-28 International Partnership for Microbicides, Inc. Platinum-catalyzed silicone drug delivery devices and methods of use thereof
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US11529308B2 (en) 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control

Also Published As

Publication number Publication date
US20200397800A1 (en) 2020-12-24
US20220054503A1 (en) 2022-02-24
CA3141077A1 (en) 2020-12-24
AU2020294780A1 (en) 2022-01-27
ZA202110288B (en) 2023-10-25
US20210290637A1 (en) 2021-09-23
US20200397801A1 (en) 2020-12-24
CO2021017509A2 (es) 2022-04-19
IL289135A (en) 2022-02-01
US10940157B2 (en) 2021-03-09
WO2020257544A1 (en) 2020-12-24
AR120976A1 (es) 2022-04-06
US10925882B2 (en) 2021-02-23
US10918649B2 (en) 2021-02-16
KR20220027979A (ko) 2022-03-08
US20200397802A1 (en) 2020-12-24
BR112021025853A2 (pt) 2022-03-03
JP2022536836A (ja) 2022-08-19
US11850251B2 (en) 2023-12-26
MX2022000047A (es) 2022-04-06
CN114364369A (zh) 2022-04-15
EP3986375A1 (en) 2022-04-27

Similar Documents

Publication Publication Date Title
CL2021003410A1 (es) Sistema para proporcionar control de la natalidad
CO2021017561A2 (es) Antibióticos macrocíclicos de amplio espectro
CO2020009625A2 (es) Inhibidor de fap
ECSP066999A (es) Envase farmacéutico para anticoncepción hormonal de régimen extendido flexible
GT201200012A (es) Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo, procedimiento para su preparacion y su uso para el tratamiento de enfermedades
CO2018006041A2 (es) Formulaciones y métodos para controlar el ciclo reproductivo y la ovulación
AR064149A1 (es) Sal fumarato de (alfa s , beta r)-6 bromo- alfa-[ 2(dimetilamino ) etil)-2- metoxi - alfa-1-naftalenil- beta- fenil-3- quinolinaetanol
DOP2021000111A (es) 3,3- difluoroalilaminas o sales de las mismas y composiciones farmacéuticas que las comprenden
BR112018073298A2 (pt) cápsula, suspensão de cápsula, mistura, uso das cápsulas e método para reduzir a nitrificação
WO2020046481A3 (en) Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease
NI201900004A (es) Composición vaginal comprendiendo una combinación de estrógeno y vitamina d.
AR031723A1 (es) Un vendaje para lesiones
AR116997A1 (es) Composiciones antitranspirantes
BR112021022689A2 (pt) Artigo gerador de aerossol compreendendo código tridimensional
CO2020005710A2 (es) Sales de (r)–9–(2,5–difluorofenetil)–4–etil–2–metil–1–oxa–4,9–diazaspiro[5.5]undecan–3–ona
WO2019094292A8 (en) Compositions and methods of providing thyroid hormone or analogs thereof
WO2016171521A3 (ko) 임신과 관련된 시알화 tn 항원의 용도
CH295269A (de) Blatt zur Herstellung einer insbesondere als Spielzeug und zu Reklamezwecken verwendbaren Mütze.
DE1611197U (de) Gestanzte klebestollen, nocken und buchstaben zum kaltvulkanisieren.
Franasiak et al. Reply: to PMID 25265402
MX2022002063A (es) Mioinositol y la prevencion de pprom.
NL163248C (nl) Werkwijze ter bereiding van kleurloze kleurvormende verbindingen, alsmede een overdrachtsvel en een kopieersysteem, waarin gebruik wordt gemaakt van deze verbindingen.
AT184417B (de) Absperrventil, insbesondere für Armaturen bei sanitären Einrichtungen
Görkem et al. Does obesity really have any effect on ovarian reserve?
WO2020046243A3 (en) Extended release osmotic tablet dosage form comprising metformin and sitagliptin